University of Tasmania Home Page Course and Units 2012
 
 This course information is for students studying under a new course structure. Switch to old course structure information.

Health Science

CSA313

Enrolment
Unit Code
Unit Title
CSA301 Research in Pharmacy A
CSA302 Research in Pharmacy B
CSA303 Research Project in Drug Science
CSA304 Medicinal Chemistry and Drug Development
CSA305 Therapeutics 3A
CSA306 Therapeutics 3B
CSA308 Pharmacology 3A
CSA309 Pharmacology 3B
CSA311 Clinical Pharmacokinetics 3
CSA312 Clinical Pharmacokinetics
CSA313 Clinical Pharmacokinetics
CSA331 Toxicology
CSA332 Toxicology
CSA333 Toxicology
CSA340 Chemotherapy and Infection
(Not Offered 2012)
CSA341 Chemotherapy and Infection
(Not Offered 2012)
CSA342 Chemotherapy and Infection
(Not Offered 2012)
CSA343 Chemotherapy and Infection
(Not Offered 2012)
CSA344 Infectious Disease
CSA351 Clinical Pharmacy Residency 3A
(Not Offered 2012)
CSA352 Clinical Pharmacy Residency 3B
(Not Offered 2012)
CSA353 Clinical Pharmacy Residency
CSA355 Pharmaceutical Science and Practice 3A
CSA356 Pharmaceutical Science and Practice 3B

2012  CSA313  Clinical Pharmacokinetics

Unit Level: Advanced

Available as a Student Elective: Yes

View timetable of lectures only for this unit.  View ALL timetable events for this unit.

SPECIAL NOTE:  Based on CSA311

OFFERINGS

Unit Sem 1 Sem 2 Full Yr Spring Summer Winter
CSA313 H

Key Semester Dates
Semester Campus Attendance Note Start Date Census Date Final WW Date* End Date
Sem 2 H On Campus 16-JUL-2012 10-AUG-2012 03-SEP-2012 20-OCT-2012

*The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see Withdrawal dates explained for more information).

About Census Dates

DESCRIPTION

Studies factors influencing the bioavailability and disposition of drugs, and the application of this information to optimise the therapeutic usefulness of drugs in clinical practice. Particular emphasis is placed on the clinical role of the pharmacist and problem-solving in improving the use of drugs through the practical application of pharmacokinetics, although this information is also applicable to students not completing a pharmacy degree.

Topics include: formulation factors and therapeutic activity; route of administration and bioavailability; developments in drug delivery; estimating drug dosage requirements in clinical practice; therapeutic drug monitoring; drug interactions; an overview of sources of inter-patient variability in pharmacokinetics (eg extremes of age, renal disease, pharmacogenomics); clinical case studies and pharmacokinetics of specific drugs.

Unit objective: (i) to develop a good practical knowledge and understanding of drug absorption with various routes of administration and factors influencing absorption (biopharmaceutics) and (ii) to develop a foundation understanding of the processes of absorption, distribution, metabolism and excretion of drugs, and how these influence dosing regime design and individualisation of dosing (pharmacokinetics). The latter is subsequently studied in more detail in CSA414 Clinical Pharmacokinetics 4.

WEIGHT:  12.5%

ASSESSMENT: 1 x 50-min mid-semester exam (15%), 1 x 2-hr exam in November (85%)

TEACHING PATTERN: 4 x 1-hr lectures weekly

REQUISITE INFO
Prereq CHP207and CHP208
Prereq Highly recommended: CSA232and CSA233

TEXTS
Information about any textbook requirements for Semester (Sem 2) will be available from mid April 2012

STAFF: Prof G Peterson

FEES
View fees for this unit

KEY

Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.

Campus - H Hobart, L Launceston, W Burnie. Study Centre - V Sydney, R Rozelle, P Beauty Point. Distance units may also have a campus identifier of I Isolated, N Interstate, O Overseas. Units delivered in Transnational Education (TNE) Programs have a campus identifier of A Hangzhou, F Fuzhou, G Shanghai, K KDU Malaysia, Q Kuwait or Y Hong Kong.

Special approval is required for enrolment into TNE Program units - campuses A, F, G, K, Q and Y click here for more information.



University of Tasmania Home Page Authorised by the Academic Registrar
© University of Tasmania | ABN 30 764 374 782
Copyright and Disclaimers | Accessibility | Feedback, Suggestions and Questions
Info Line 1300 363 864